Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
批准号:
8197449
负责人:
XIAODONG CHENG
金额:
$34.46万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-01 至 2013-11-30
关键词:
Abnormal CellBindingBiochemicalBiological ProcessChemotherapy-Oncologic ProcedureCollaborationsComplexCyclic AMPCyclic AMP ReceptorsCyclic AMP-Dependent Protein KinasesDataDeuteriumDevelopmentDiabetes MellitusDiagnosisDiseaseDrug Delivery SystemsDrug effect disorderEukaryotic CellGoalsGrantGuanine Nucleotide Exchange FactorsHeart failureHoloenzymesHydrogenIntracellular Second MessengerKnowledgeLeadLengthLiteratureMalignant NeoplasmsMapsMass Spectrum AnalysisMediatingMedicalModelingMolecularMolecular ConformationMotionPhysiologicalPlayPositioning AttributeProteinsPublishingRegulationResearchRoentgen RaysRoleSecond Messenger SystemsSignal PathwaySignal TransductionSite-Directed MutagenesisSolutionsStructural ModelsStructureTechniquesTestingTherapeuticTherapeutic AgentsWood materialX-Ray Crystallographybasecell growthcomparativedesignfactor Aimprovedinnovationnovelprogramsresearch studythree dimensional structure
中文摘要
cAMP介导的信号传导调节生理条件下的无数重要的生物学过程。
条件和疾病状态,包括糖尿病、心力衰竭和癌症。在真核细胞中,
cAMP由两种普遍表达的细胞内cAMP受体介导,
A/cAMP依赖性蛋白激酶(PKA/cAPK)和最近发现的直接激活的交换蛋白
cAMP/cAMP调节的鸟嘌呤核苷酸交换因子(Epac/cAMP-GEF)。存在两
普遍表达的cAMP效应物提供了一种更精确和综合控制细胞凋亡的机制。
cAMP信号通路的空间和时间的方式。然而,关于其机制知之甚少。
Epac激活。本提案的目的是通过绘制
与Epac激活相关的构象变化。具体来说,我们计划用
以下具体目的:1)通过定点突变确定对Epac活化重要的特定残基,
诱变; 2)描绘与cAMP结合和Epac活化相关的构象变化
并使用增强的免疫荧光技术,
氘交换质谱(DXMS)和小角X射线散射;和3)解决晶体
使用X射线晶体学的Epac 2-cAMP的结构。我们研究的长期目标是了解
Epac调节的生理功能和机制。完成这项拟议的研究,
应用将大大推动该领域朝着这些目标前进。此外,医疗和
这项研究计划的药理学意义也是深远的。更好地了解cAMP-
介导的信号转导可能导致识别新的机制为基础的治疗
特别针对cAMP信号传导组分的策略。
英文摘要
cAMP-mediated signaling regulates a myriad of important biological processes under physiological
conditions and disease states, including diabetes, heart failure and cancer. In eukaryotic cells, the effects of
cAMP are mediated by two ubiquitously expressed intracellular cAMP receptors, the classic protein kinase
A/cAMP-dependent protein kinase (PKA/cAPK) and the recently discovered exchange protein directly activated
by cAMP/cAMP-regulated guanine nucleotide exchange factor (Epac/cAMP-GEF). The existence of two
ubiquitously expressed cAMP effectors provides a mechanism for a more precise and integrated control of the
cAMP signaling pathways in a spatial and temporal manner. However, little is known about the mechanism of
Epac activation. The objective of this proposal is to fill the gap in our current knowledge by mapping the
conformational changes associated with Epac activation. Specifically, we have planned experiments with the
following Specific Aims: 1) To determine the specific residues important for Epac activation by site-directed
mutagenesis; 2) to delineate the conformational changes associated with cAMP binding and Epac activation
and to determine the protein interface between Epac and it's downstream effector, Rap1, using enhanced
deuterium exchange-mass spectrometry (DXMS) and small-angle X-ray scattering; and 3) to solve the crystal
structure of Epac2-cAMP using X-ray crystallography. The long-term goals of our research are to understand
the physiological functions and mechanisms of Epac regulation. Accomplishing the proposed research in this
application will significantly move the field forward towards these goals. Furthermore, the medical and
pharmacological implications of this research program are also far-reaching. A better understanding of cAMP-
mediated signal transduction could potentially lead to the identification of novel mechanism-based therapeutic
strategies specifically targeting the cAMP-signaling components.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Significance of Epac signaling in renal Na+ handling and hypertension
-
批准号:10864073
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2023
-
负责人:XIAODONG CHENG
-
依托单位:
Epac1 as a novel therapeutic target for diabetic retinopathy
-
批准号:10689112
-
项目类别:
-
资助金额:$50.62万
-
财政年份:2022
-
负责人:XIAODONG CHENG
-
依托单位:
Exchange Protein directly Activated by cAMP (EPAC): Structure, Function and Therapeutics
-
批准号:10198941
-
项目类别:
-
资助金额:$42.85万
-
财政年份:2017
-
负责人:XIAODONG CHENG
-
依托单位:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
-
批准号:9250048
-
项目类别:
-
资助金额:$120.96万
-
财政年份:2014
-
负责人:XIAODONG CHENG
-
依托单位:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
-
批准号:9038248
-
项目类别:
-
资助金额:$125.62万
-
财政年份:2014
-
负责人:XIAODONG CHENG
-
依托单位:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
-
批准号:8694342
-
项目类别:
-
资助金额:$153.87万
-
财政年份:2014
-
负责人:XIAODONG CHENG
-
依托单位:
Novel Pharmacological Probes Targeting Exchange Proteins Activated by cAMP (EPAC)
-
批准号:8482964
-
项目类别:
-
资助金额:$49.11万
-
财政年份:2013
-
负责人:XIAODONG CHENG
-
依托单位:
High throughput assay for novel pharmacological probes targeting cAMP signaling
-
批准号:8477859
-
项目类别:
-
资助金额:$3.83万
-
财政年份:2010
-
负责人:XIAODONG CHENG
-
依托单位:
High throughput assay for novel pharmacological probes targeting cAMP signaling
-
批准号:7991500
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2010
-
负责人:XIAODONG CHENG
-
依托单位:
Genetic Screening:Oncogene RAS-Based Inhibi*(RMI)
-
批准号:7058055
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2005
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:6743684
-
项目类别:
-
资助金额:$27.12万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:6888183
-
项目类别:
-
资助金额:$27.12万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:7994210
-
项目类别:
-
资助金额:$34.39万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:9260012
-
项目类别:
-
资助金额:$37.26万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:7238664
-
项目类别:
-
资助金额:$25.71万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:8762253
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:7583771
-
项目类别:
-
资助金额:$35.8万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:8783945
-
项目类别:
-
资助金额:$23.42万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:8387786
-
项目类别:
-
资助金额:$9.56万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:7059367
-
项目类别:
-
资助金额:$26.48万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: